Distek, Inc. Releases the LabEye Digital Video System

North Brunswick, NJ – Distek, Inc., an industry leader in pharmaceutical laboratory testing instruments, accessories and validation services, is excited to release the LabEye Digital Video System for Dissolution testing monitoring and recording. The LabEye Digital Video System, engineered by TwoSquare Science streamlines pharmaceutical testing in both R&D and Quality environments. Designed specifically for laboratory [...]

UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative

SAN DIEGO -- BioNano Genomics announced today the purchase of an Irys™ System by UC Davis to assist, among other projects, in completing the genome assembly of Aegilops tauschii, one of three progenitors of today's bread wheat. The team of researchers at UC Davis, led by Dr. Jan Dvorak, will use the Irys System in [...]

LabCorp to Offer New FDA approved Breast Cancer Prognostic Test

BURLINGTON, N.C. -- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the launch of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay, an FDA approved breast cancer prognostic gene signature assay developed by NanoString Technologies, Inc. Prosigna provides a risk category and a numerical score to assess the probability of breast cancer recurrence [...]

Bruker Corporation Announces the Appointment of Dr. Gilles Martin to its Board of Directors

BILLERICA, Mass. -- Bruker Corporation (NASDAQ:BRKR) announced the election of Dr. Gilles Martin to its Board of Directors, effective as of today. Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group, a Luxembourg-based international life-sciences company which provides a range of analytical testing services to clients across multiple industries. Dr. Martin [...]

Agilent Technologies Awards Grant for Translational Research in Cardiometabolic Disease

SANTA CLARA, Calif.-- Agilent Technologies Inc. (NYSE: A) today announced it has awarded a grant to the newly established Duke Molecular Physiology Institute. The DMPI research team is using Agilent's integrated biology solutions to gain new insights into the metabolic and physiologic aspects of major chronic diseases such as cardiovascular disease. DMPI is headed by [...]

University of Bristol collaborates with Affymetrix on genotyping arrays for guaranteed sustainability of wheat production

SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX) and University of Bristol, Bristol, UK, announced today that they have collaboratively designed a wheat genotyping array and analyzed data from experiments as part of an effort to understand wheat genetics and breeding with a goal of ensuring guaranteed sustainable production. Axiom® Wheat Genotyping Array (Axiom Wheat [...]

MedMira Embarks on Major U.S. Expansion with VWR International, LLC Agreement

Halifax, Nova Scotia – MedMira Inc., (MedMira) (TSXV: MIR), a developer of rapid testing technologies and solutions, today announced a U.S. distribution agreement with VWR International LLC, a global solutions provider of laboratory supplies and services with worldwide sales in excess of $4.1 billion in 2012. Through this new agreement, MedMira will benefit from the [...]

New Laboratory Test Helps Hospitals Detect Newly Emerging Strains of Drug-Resistant Superbug

Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has received FDA clearance to market the BD MAX™ MRSA XT Assay for use on the fully-automated BD MAX™ System. This is the second assay from BD Diagnostics capable of detecting [...]

QIAGEN and Exosome Diagnostics to develop first-in-class, non-invasive diagnostics for key genetic biomarkers in lung and other cancers

GERMANTOWN, Maryland, and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced an expansion of its strategic partnership with Exosome Diagnostics Inc. to develop a first-in-class, non-invasive molecular in-vitro diagnostics for use in diagnosing and monitoring patients. The novel blood based diagnostic detects certain mutations of an undisclosed gene associated with [...]

NanoString Technologies Files Registration Statement With SEC for a Follow-On Public Offering

SEATTLE -- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed follow-on public offering of $55 million of its common stock. In addition, the Company expects to grant the [...]

Access IBO on Knowledge Center